Clinical Trial Update: ACTIMMUNE in Intermediate Osteopetrosis [Phase 2]

View source ↗

Summary

An update on ACTIMMUNE (interferon gamma-1b) for intermediate osteopetrosis reports completion of a Phase 2 clinical trial with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteopetrosis

Drugs mentioned

• ACTIMMUNE (interferon gamma-1b)

Snippet

Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | Conditions: Osteopetrosis | Phase 2 | Status: COMPLETED | Results posted: 2023-10-11